Director Dimension Capital acquires 2.8M shares for $20M in largest open-market purchase; six insiders buy within two weeks.
L.P. Dimension Capital II, a director of Odyssey Therapeutics, executed a substantial open-market acquisition involving both a conversion of existing holdings and a market purchase totaling nearly 2.8 million shares—more than doubling the director's position. This is the director's first open-market purchase in the three-year filing window. The transaction occurs within a two-week window in which six insiders collectively purchased shares, representing a notable clustering of insider buying activity. The stock is currently trading above its recent range, suggesting the director is willing to accumulate shares at current valuations despite the stock's recent trajectory.